Riskpilot← Back to searchSign inGet full accessVivalla Vårdcentral AB
ABActiveOrg 5568730476Poesigatan 20 DGeneral medical practice activities · NACE 8621Est. 201133 employees
Revenue 2025
SEK 53,2M
+12% vs 2024
EBITDA margin
11.8%
+49% vs 2024
Equity ratio
43.1%
Financial strength
Net profit 2025
SEK 5M
+48% vs 2024
| Revenue | SEK 53,2M | +12% |
| EBITDA | SEK 6,3M | +49% |
| Net profit | SEK 5M | +48% |
| Total assets | SEK 11,8M | +29% |
| Equity | SEK 5,1M | +48% |
| Employees | 33 | — |
Legal name
Vivalla Vårdcentral AB
Org number
5568730476
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 november 2011
Share capital
SEK 50 000
Employees
33 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva öppern sjuk- och hälsovård samt därmed förenlig verksamhet.
Address
Poesigatan 20 D
Phone
+46196024115
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 46 020 | 46 627 | 46 986 | 47 363 | 53 184 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 352 | 1 776 | 2 943 | 4 202 | 6 272 |
| Depreciation & amort. | −116 | −83 | −70 | −51 | −20 |
| EBIT | 4 236 | 1 693 | 2 873 | 4 151 | 6 252 |
| Net financials | — | — | 48 | 150 | 109 |
| Profit before tax | 4 206 | 1 657 | 2 884 | 4 271 | 6 338 |
| Tax | −877 | −352 | −604 | −903 | −1 337 |
| Net profit | 3 329 | 1 305 | 2 280 | 3 368 | 5 001 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 8 847 | 7 798 | 8 225 | 9 134 | 11 750 |
| Equity | 3 380 | 1 357 | 2 330 | 3 428 | 5 060 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 467 | 6 441 | 5 895 | 5 705 | 6 690 |
| Total debt | 5 467 | 6 441 | 5 895 | 5 705 | 6 690 |
EBITDA margin
11.8%
This company
15.8%
Market median
-25% vs market
20212025
Equity ratio
43.1%
This company
38.2%
Market median
+13% vs market
20212025
Return on equity
98.8%
This company
18.4%
Market median
+437% vs market
20212025
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20212025
Asset turnover
4.53×
This company
1.12×
Market median
+304% vs market
20212025
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JB Chief Auditor | Chief Auditor | 2024 |
| Former (1) | ||
GM Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vivalla Vårdbolag Aktiebolag
Vivalla Vårdcentral AB Board members of Vivalla Vårdcentral AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnel Maria Körkkö | Audit | 0 companies |
| Johanna Britt Cecilia Mossberg | Chief Auditor | 0 companies |
| Eva Marie-Louise Jonsson | Deputy Board Member | 0 companies |
| Hans Rune Holmgren | Board of Directors | 0 companies |
| Inger Ester Elisabet Vetterskog | Deputy Board Member | 0 companies |
| Kurt Alvar Vetterskog | Chairman | 0 companies |